Leiomyoma
Therapeutic area
Neuromuscular Disease
Rare disease
No
- Definition
- A well-circumscribed benign smooth muscle neoplasm characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Leiomyoma
- Therapeutic area
- Neuromuscular Disease
- leiomyoma
- fibroid
- fibroid neoplasm
- fibroid tumor
- fibroid tumour
- leiomyoma, benign
- leiomyomatous neoplasm (morphologic abnormality)
- leiomyomatous tumour
- Severity
- Mild
- Neuromuscular Disease
- Oncology
- Rheumatology
- MONDO ID
- MONDO:0001572
- Parent condition
- MONDO:0006106
Related records
Broader conditions (16)
- Benign muscle neoplasm
- Benign neoplasm
- Benign smooth muscle neoplasm
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Human disease
- Mesenchymal cell neoplasm
- Muscle tissue disorder
- Musculoskeletal system benign neoplasm
- Musculoskeletal system disorder
- Myomatous neoplasm
- Neoplasm
- Neoplastic disease or syndrome
- Smooth muscle tumor
Narrower conditions (51)
- Anus leiomyoma
- Appendix leiomyoma
- Benign metastasizing leiomyoma
- Bizarre leiomyoma
- Bladder leiomyoma
- Breast leiomyoma
- Cellular leiomyoma
- Central nervous system leiomyoma
- Colon leiomyoma
- Colorectal leiomyoma
- Dartoic leiomyoma
- Deep leiomyoma
- Disseminated peritoneal leiomyomatosis
- Endobronchial leiomyoma
- Esophagus leiomyoma
- Extrahepatic bile duct leiomyoma
- Fallopian tube leiomyoma
- Gallbladder leiomyoma
- Gastric leiomyoma
- Intravenous leiomyomatosis
Trials (420)
- 3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas
- 3D Ultrasound to Assess in Recurrent Miscarriage
- 4K Versus 3D Laparoscopic Colporraphy by Surgeons in Training: a Prospective Randomized Trial
- A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets
- A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
- A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
- A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery
- A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids
- A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.
- A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
- A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids
- A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.
- A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
- A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
- A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device
- A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids
- A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids
- A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
- A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma
Approved drugs (1)
- Ulipristal acetate
Drugs in development (13)
- Asoprisnil Phase 3
- Dexamethasone Phase 3
- Leuprolide Phase 3
- Lidocaine Phase 2
- Linzagolix Phase 3
- Mifepristone Phase 3
- Misoprostol Phase 3
- Onabotulinumtoxina Phase 2
- Ropivacaine Phase 2
- Sodium chloride Phase 3
- Ulipristal Phase 2
- Vasopressin Phase 2
- Vilaprisan Phase 3